# Contact — Thymosin Alpha-1 Source Editorial Desk

> Contact Thymosin Alpha-1 Source: corrections, citation questions, and editorial feedback on our research digest. We do not sell products or give medical advice.

Corrections, citation questions, and editorial feedback — we read every note.

## Reach the editorial desk

Use the form below to reach the people behind Thymosin Alpha-1 Source. We especially welcome corrections: if a citation looks misattributed, a number looks off, or a study has been superseded, tell us and we will check it against the source. Because the value of this project is accuracy, well-sourced corrections get priority.

## What we can and can't help with

We can help with editorial matters — citation questions, corrections, clarifications about how we read a study, and feedback on the summaries. We cannot offer medical advice, dosing guidance, or treatment recommendations, and we cannot tell you whether Thymosin Alpha-1 is appropriate for any individual; those are questions for a qualified clinician. We also do not sell, supply, or source the peptide, and we cannot point you to vendors.

## A note on scope

Thymosin Alpha-1 Source is an editorial publisher, not a healthcare provider. We have no clinic, no clinical staff, and no products. Everything we publish is commentary on the public research record. If your question is about your own health, please consult a licensed professional rather than this site.

---

A forward but evidence-graded reading of the Thymosin Alpha-1 record — the four-decade hepatitis and immune-restoration signal read first, the null phase-3 sepsis trial held in plain view, the molecule kept distinct from thymosin beta-4, and the community reports fenced off as unverified; an open reading desk, not a clinic, and nothing here dosed, sourced, prescribed, or sold.